AbCellera Biologics, Inc. (ABCL)
12.07
+1.46
(+13.76%)
USD |
NASDAQ |
Aug 25, 10:59
AbCellera Biologics Market Cap : 3.699B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.252B |
| August 21, 2026 | 3.469B |
| August 20, 2026 | 3.546B |
| August 19, 2026 | 3.681B |
| August 18, 2026 | 3.408B |
| August 17, 2026 | 3.432B |
| August 14, 2026 | 3.488B |
| August 13, 2026 | 3.362B |
| August 12, 2026 | 3.173B |
| August 11, 2026 | 2.991B |
| August 10, 2026 | 2.862B |
| August 07, 2026 | 2.124B |
| August 06, 2026 | 2.001B |
| August 05, 2026 | 1.814B |
| August 04, 2026 | 1.866B |
| August 03, 2026 | 1.787B |
| July 31, 2026 | 1.736B |
| July 30, 2026 | 1.729B |
| July 29, 2026 | 1.638B |
| July 28, 2026 | 1.608B |
| July 27, 2026 | 1.596B |
| July 24, 2026 | 1.614B |
| July 23, 2026 | 1.723B |
| July 22, 2026 | 1.742B |
| July 21, 2026 | 1.815B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.763B |
| July 17, 2026 | 1.965B |
| July 16, 2026 | 1.872B |
| July 15, 2026 | 2.049B |
| July 14, 2026 | 2.049B |
| July 13, 2026 | 1.982B |
| July 10, 2026 | 2.067B |
| July 09, 2026 | 2.216B |
| July 08, 2026 | 2.158B |
| July 07, 2026 | 2.337B |
| July 06, 2026 | 2.392B |
| July 02, 2026 | 2.465B |
| July 01, 2026 | 2.310B |
| June 30, 2026 | 2.386B |
| June 29, 2026 | 2.468B |
| June 26, 2026 | 2.243B |
| June 25, 2026 | 2.024B |
| June 24, 2026 | 1.833B |
| June 23, 2026 | 1.711B |
| June 22, 2026 | 1.745B |
| June 18, 2026 | 1.681B |
| June 17, 2026 | 1.653B |
| June 16, 2026 | 1.547B |
| June 15, 2026 | 1.599B |
| June 12, 2026 | 1.593B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Jazz Pharmaceuticals Plc | 17.22B |
| Danaher Corp. | 151.91B |
| Illumina, Inc. | 33.72B |
| Bio-Techne Corp. | 11.33B |
| Waters Corp. | 40.45B |
Market Cap Related Metrics
| PS Ratio | 55.09 |
| Price to Book Value | 4.128 |
| Price | 12.07 |
| Earnings Yield | -4.51% |